000167373 001__ 167373
000167373 005__ 20240229133538.0
000167373 0247_ $$2doi$$a10.1002/ijc.33504
000167373 0247_ $$2pmid$$apmid:33554339
000167373 0247_ $$2ISSN$$a0020-7136
000167373 0247_ $$2ISSN$$a1097-0215
000167373 0247_ $$2altmetric$$aaltmetric:99804080
000167373 037__ $$aDKFZ-2021-00317
000167373 041__ $$aeng
000167373 082__ $$a610
000167373 1001_ $$00000-0002-2453-0183$$aJayasekara, Harindra$$b0
000167373 245__ $$aLifetime alcohol intake, drinking patterns over time, and risk of stomach cancer: a pooled analysis of data from two prospective cohort studies.
000167373 260__ $$aBognor Regis$$bWiley-Liss$$c2021
000167373 3367_ $$2DRIVER$$aarticle
000167373 3367_ $$2DataCite$$aOutput Types/Journal article
000167373 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1625044124_11425
000167373 3367_ $$2BibTeX$$aARTICLE
000167373 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000167373 3367_ $$00$$2EndNote$$aJournal Article
000167373 500__ $$a148(11):2759-2773
000167373 520__ $$aAlcohol consumption is causally linked to several cancers but the evidence for stomach cancer is inconclusive. In our study, the association between long-term alcohol intake and risk of stomach cancer and its subtypes was evaluated. We performed a pooled analysis of data collected at baseline from 491,714 participants in the European Prospective Investigation into Cancer and Nutrition and the Melbourne Collaborative Cohort Study. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated for incident stomach cancer in relation to lifetime alcohol intake and group-based life course intake trajectories, adjusted for potential confounders including Helicobacter pylori infection. 1,225 incident stomach cancers (78% non-cardia) were diagnosed over 7,094,637 person-years; 984 in 382,957 study participants with lifetime alcohol intake data (5,455,507 person-years). Although lifetime alcohol intake was not associated with overall stomach cancer risk, we observed a weak positive association with non-cardia cancer (HR=1.03, 95% CI: 1.00-1.06 per 10 g/day increment), with a HR of 1.50 (95% CI: 1.08-2.09) for ≥60 g/day compared with 0.1-4.9 g/day. A weak inverse association with cardia cancer (HR=0.93, 95% CI: 0.87-1.00) was also observed. HRs of 1.48 (95% CI: 1.10-1.99) for non-cardia and 0.51 (95% CI: 0.26-1.03) for cardia cancer were observed for a life course trajectory characterized by heavy decreasing intake compared with light stable intake (phomogeneity =0.02). These associations did not differ appreciably by smoking or Helicobacter pylori infection status. Limiting alcohol use during lifetime, particularly avoiding heavy use during early adulthood, might help prevent non-cardia stomach cancer. Heterogeneous associations observed for cardia and non-cardia cancers may indicate etiologic differences.
000167373 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000167373 588__ $$aDataset connected to CrossRef, PubMed,
000167373 650_7 $$2Other$$aEPIC
000167373 650_7 $$2Other$$aLifetime alcohol intake
000167373 650_7 $$2Other$$aMCCS
000167373 650_7 $$2Other$$acardia cancer
000167373 650_7 $$2Other$$anon-cardia cancer
000167373 650_7 $$2Other$$astomach cancer
000167373 7001_ $$aMacInnis, Robert J$$b1
000167373 7001_ $$aBarroso, Leila Lujan$$b2
000167373 7001_ $$aMayen-Chacon, Ana-Lucia$$b3
000167373 7001_ $$aCross, Amanda J$$b4
000167373 7001_ $$aWallner, Bengt$$b5
000167373 7001_ $$00000-0002-5558-2437$$aPalli, Domenico$$b6
000167373 7001_ $$00000-0001-8749-9737$$aRicceri, Fulvio$$b7
000167373 7001_ $$aPala, Valeria$$b8
000167373 7001_ $$aPanico, Salvatore$$b9
000167373 7001_ $$aTumino, Rosario$$b10
000167373 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b11$$udkfz
000167373 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b12$$udkfz
000167373 7001_ $$00000-0002-8452-8472$$aTsilidis, Kostas$$b13
000167373 7001_ $$aSánchez, Maria-Jose$$b14
000167373 7001_ $$aAmiano, Pilar$$b15
000167373 7001_ $$aArdanaz, Eva$$b16
000167373 7001_ $$aLópez, María Dolores Chirlaque$$b17
000167373 7001_ $$aMerino, Susana$$b18
000167373 7001_ $$aRothwell, Joseph A$$b19
000167373 7001_ $$00000-0002-5956-5693$$aBoutron-Ruault, Marie-Christine$$b20
000167373 7001_ $$aSeveri, Gianluca$$b21
000167373 7001_ $$aSternby, Hanna$$b22
000167373 7001_ $$aSonestedt, Emily$$b23
000167373 7001_ $$aBueno-de-Mesquita, Bas$$b24
000167373 7001_ $$aBoeing, Heiner$$b25
000167373 7001_ $$aTravis, Ruth$$b26
000167373 7001_ $$aSandanger, Torkjel M$$b27
000167373 7001_ $$aTrichopoulou, Antonia$$b28
000167373 7001_ $$aKarakatsani, Anna$$b29
000167373 7001_ $$aPeppa, Eleni$$b30
000167373 7001_ $$aTjønneland, Anne$$b31
000167373 7001_ $$aYang, Yi$$b32
000167373 7001_ $$00000-0001-5464-2197$$aHodge, Allison M$$b33
000167373 7001_ $$aMitchell, Hazel$$b34
000167373 7001_ $$aHaydon, Andrew$$b35
000167373 7001_ $$aRoom, Robin$$b36
000167373 7001_ $$aHopper, John L$$b37
000167373 7001_ $$00000-0003-2237-0128$$aWeiderpass, Elisabete$$b38
000167373 7001_ $$aGunter, Marc J$$b39
000167373 7001_ $$aRiboli, Elio$$b40
000167373 7001_ $$aGiles, Graham G$$b41
000167373 7001_ $$aMilne, Roger L$$b42
000167373 7001_ $$aAgudo, Antonio$$b43
000167373 7001_ $$aEnglish, Dallas R$$b44
000167373 7001_ $$00000-0001-9358-7338$$aFerrari, Pietro$$b45
000167373 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.33504$$gp. ijc.33504$$n11$$p2759-2773$$tInternational journal of cancer$$v148$$x1097-0215$$y2021
000167373 909CO $$ooai:inrepo02.dkfz.de:167373$$pVDB
000167373 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000167373 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000167373 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000167373 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000167373 9141_ $$y2021
000167373 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-08-32$$wger
000167373 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2020-08-32$$wger
000167373 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2018$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-32
000167373 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-08-32
000167373 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000167373 980__ $$ajournal
000167373 980__ $$aVDB
000167373 980__ $$aI:(DE-He78)C020-20160331
000167373 980__ $$aUNRESTRICTED